0001209191-23-040108.txt : 20230628
0001209191-23-040108.hdr.sgml : 20230628
20230628210018
ACCESSION NUMBER: 0001209191-23-040108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230627
FILED AS OF DATE: 20230628
DATE AS OF CHANGE: 20230628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHNEIDER PHILLIP M
CENTRAL INDEX KEY: 0001230051
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39756
FILM NUMBER: 231053976
MAIL ADDRESS:
STREET 1: GEN-PROBE INCORPORATED
STREET 2: 10210 GENETIC CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001671858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-771-9307
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Silverback Therapeutics, Inc.
DATE OF NAME CHANGE: 20160412
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-27
0
0001671858
ARS Pharmaceuticals, Inc.
SPRY
0001230051
SCHNEIDER PHILLIP M
C/O ARS PHARMACEUTICALS, INC.
11682 EL CAMINO REAL, SUITE 120
SAN DIEGO
CA
92130
1
0
0
0
0
Stock Option (right to buy)
6.50
2023-06-27
4
A
0
40000
0.00
A
2033-06-26
Common Stock
40000
40000
D
The shares subject to the option will vest in full on the earlier of June 27, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.
/s/ Kathleen Scott, Attorney-in-Fact
2023-06-28